Senior insider sale
Chief Medical Officer at BIOAGE LABS, INC. — senior position signals high conviction
$540.8K
31.12K shares
What this filing means
RUBIN PAUL D plans to sell 31.12K shares of BIOAGE LABS, INC. valued at approximately $540.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2026ACC: 0001959173-26-002686
Officer· Chief Medical Officer
Since Mar 2026
31.12K
Shares to sell
$540.8K
Approx. market value
8.82K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Option Granted 05/29/2022
Cash
4/1/2026
3.38KOption Granted 07/01/2020
Cash
4/1/2026
5.44KTotal acquired8.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Option Granted 05/29/2022 Cash | 3.38K | — |
4/1/2026 | Option Granted 07/01/2020 Cash | 5.44K | — |
| Total | 8.82K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.43K
Market value
$148.9K
3/2/2026
—Completed
Units to sell
7.43K
Market value
$139.4K
2/2/2026
—Completed
Units to sell
7.43K
Market value
$95.5K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.82K
Market value
$157.1K
4/1/2026
Total
Units
31.12K
Value
$540.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 7.43K | $148.9K | — | Completed |
2/2/2026 | 7.43K | $139.4K | — | Completed |
1/2/2026 | 7.43K | $95.5K | — | Completed |
| Planned — Approximate Date | ||||
4/1/2026 | 8.82K | $157.1K | NASDAQ | Planned |
| Total | 31.12K | $540.8K | ||